Showing results (1471-1480 of 2,693) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|November 5, 2020
SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort studyOon Tek Ng, Kalisvar Marimuthu, Vanessa Koh, et al.
The Lancet. Infectious Diseases|November 19, 2020
Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with five commercially available immunoassays: a retrospective analysis of phase 3 efficacy trialsCarlos A DiazGranados, Matthew Bonaparte, Hao Wang, et al.
The Lancet. Infectious Diseases|November 20, 2020
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trialAndrew J Pollard, Odile Launay, Jean-Daniel Lelievre, et al.
The Lancet. Infectious Diseases|October 22, 2020
Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysisWan Yang, Sasikiran Kandula, Mary Huynh, et al.
The Lancet. Infectious Diseases|November 8, 2020
Arthritogenic alphaviruses: epidemiological and clinical perspective on emerging arbovirusesAli Zaid, Felicity J Burt, Xiang Liu, et al.
The Lancet. Infectious Diseases|November 1, 2020
Incidence of influenza during pregnancy and association with pregnancy and perinatal outcomes in three middle-income countries: a multisite prospective longitudinal cohort studyFatimah S Dawood, Wanitchaya Kittikraisak, Archana Patel, et al.
The Lancet. Infectious Diseases|November 1, 2020
Summary of evidence to reduce the two-dose infant priming schedule to a single dose of the 13-valent pneumococcal conjugate vaccine in the national immunisation programme in the UKShamez N Ladhani, Nick Andrews, Mary E Ramsay
The Lancet. Infectious Diseases|September 5, 2020
Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysisJulie Schenk, Steven Abrams, Heidi Theeten, et al.
The Lancet. Infectious Diseases|September 6, 2020
Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trialJudith Absalon, Nathan Segall, Stan L Block, et al.
The Lancet. Infectious Diseases|September 19, 2020
Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trialLorenz Leitner, Aleksandre Ujmajuridze, Nina Chanishvili, et al.
Pageof 270